Pdt Partners, LLC Syndax Pharmaceuticals Inc Transaction History

Pdt Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$8.94 - $20.98 $109,068 - $255,956	-12,200 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$6.65 - $12.03 $81,130 - $146,766	12,200 New	12,200 $134,000
Q2 2018 Aug 14, 2018	SELL	$6.93 - $14.63 $768,301 - $1.62 Million	-110,866 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$8.71 - $14.82 $472,177 - $803,407	54,211 Added 95.69%	110,866 $1.58 Million
Q4 2017 Feb 14, 2018	BUY	$7.8 - $12.94 $441,909 - $733,115	56,655	56,655 $496,000

229

88.4M

1.01M

692K

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $742M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.